![Antonin Rollet de Fougerolles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonin Rollet de Fougerolles
Directeur/Membre du Conseil chez
DEEPMATTER GROUP PLC
Profil
Antonin Rollet de Fougerolles is currently the Chairman at eTheRNA immunotherapies NV.
He is also a Director at Chimeron Bio Corp., Walking Fish Therapeutics, Inc., and a Non-Executive Director at ChemAI Ltd. Previously, he served as the Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024.
He was the Chief Scientific Officer at Tolerx, Inc. in 2010-2011 and at Ablynx NV from 2013 to 2018.
Additionally, he held the position of VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010.
Dr. de Fougerolles obtained a doctorate degree from Harvard University.
Postes actifs de Antonin Rollet de Fougerolles
| Sociétés | Poste | Début |
|---|---|---|
| DEEPMATTER GROUP PLC | Directeur/Membre du Conseil | 27/11/2024 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Directeur/Membre du Conseil | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Directeur/Membre du Conseil | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Président | 10/07/2024 |
Anciens postes connus de Antonin Rollet de Fougerolles
| Sociétés | Poste | Fin |
|---|---|---|
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Directeur Général | 29/04/2024 |
| ABLYNX | Directeur Technique/Scientifique/R&D | 01/02/2018 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Directeur Technique/Scientifique/R&D | 19/12/2011 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Directeur Technique/Scientifique/R&D | - |
Formation de Antonin Rollet de Fougerolles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
